$PPHM Peregrine Pharma: We View The Risk/Reward Profile As Favorable, Says Roth Capital http://www.smarteranalyst.com/2014/10/31/peregrine-pharma-we-view-the-riskreward-profile-as-favorable-says-roth-capital/